Martha Kingman

526 total citations
21 papers, 305 citations indexed

About

Martha Kingman is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Martha Kingman has authored 21 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 16 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Martha Kingman's work include Pulmonary Hypertension Research and Treatments (21 papers), Heart Failure Treatment and Management (11 papers) and Cardiovascular Issues in Pregnancy (7 papers). Martha Kingman is often cited by papers focused on Pulmonary Hypertension Research and Treatments (21 papers), Heart Failure Treatment and Management (11 papers) and Cardiovascular Issues in Pregnancy (7 papers). Martha Kingman collaborates with scholars based in United States, Belgium and South Korea. Martha Kingman's co-authors include Kelly Chin, Ferràn Torres, Sandra Lombardi, Rosechelle Ruggiero, Jean‐Luc Vachiéry, Fernando Torres, John J. Warner, Ronald M. Peshock, Sharon C. Reimold and James A. de Lemos and has published in prestigious journals such as CHEST Journal, The American Journal of Cardiology and BMJ Open.

In The Last Decade

Martha Kingman

19 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Kingman United States 9 262 194 41 26 24 21 305
Diane Pinder United States 6 276 1.1× 173 0.9× 21 0.5× 39 1.5× 28 1.2× 8 328
J.-L. Jagot France 4 354 1.4× 216 1.1× 79 1.9× 29 1.1× 51 2.1× 8 374
K. Akaya Smith United States 8 221 0.8× 138 0.7× 26 0.6× 28 1.1× 33 1.4× 14 256
Kristine Wynne United States 4 178 0.7× 121 0.6× 21 0.5× 24 0.9× 24 1.0× 4 212
Nabila Kadaoui France 3 441 1.7× 164 0.8× 53 1.3× 38 1.5× 27 1.1× 4 470
Thomas Viethen Germany 7 108 0.4× 118 0.6× 28 0.7× 14 0.5× 9 0.4× 15 218
Paul Sephton United Kingdom 3 353 1.3× 212 1.1× 70 1.7× 16 0.6× 23 1.0× 7 362
R.F. Roscigno United States 8 313 1.2× 216 1.1× 67 1.6× 40 1.5× 31 1.3× 14 359
Carmen Bernis Spain 8 46 0.2× 84 0.4× 23 0.6× 33 1.3× 29 1.2× 14 360
Qixian Zeng China 9 169 0.6× 131 0.7× 28 0.7× 37 1.4× 11 0.5× 36 240

Countries citing papers authored by Martha Kingman

Since Specialization
Citations

This map shows the geographic impact of Martha Kingman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Kingman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Kingman more than expected).

Fields of papers citing papers by Martha Kingman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Kingman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Kingman. The network helps show where Martha Kingman may publish in the future.

Co-authorship network of co-authors of Martha Kingman

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Kingman. A scholar is included among the top collaborators of Martha Kingman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Kingman. Martha Kingman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shlobin, Oksana A., Martha Kingman, Hafizur Rahman, et al.. (2024). Practices affEcting macitentan and selexipag patient persistence Rates utilizing pulmonary arterial hypertension clinical Site and patIent perSpecTives (PERSIST): a US qualitative analysis. Pulmonary Circulation. 14(4). e12441–e12441. 1 indexed citations
3.
Kingman, Martha, et al.. (2022). Clinical application of risk assessment in PAH: Expert center APRN recommendations. Pulmonary Circulation. 12(3). e12106–e12106. 8 indexed citations
6.
Kingman, Martha, et al.. (2018). Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective. Pulmonary Therapy. 4(1). 13–27. 14 indexed citations
7.
Lombardi, Sandra, et al.. (2018). Titration of pulmonary arterial hypertension therapeutics: Experience-based recommendations. Respiratory Medicine. 143. 139–146. 5 indexed citations
8.
Kingman, Martha, et al.. (2017). Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension. Pulmonary Circulation. 7(3). 598–608. 44 indexed citations
9.
Kingman, Martha, et al.. (2017). Riociguat in PAH and CTEPH: Strategies for Patient Management. Pulmonary Therapy. 3(1). 31–43. 2 indexed citations
10.
Kingman, Martha & Sandra Lombardi. (2016). Management of the patient with pulmonary arterial hypertension receiving intravenous prostacyclin: an expert nurse practical guide.. PubMed. 37(6). 442–51. 4 indexed citations
12.
Kingman, Martha, et al.. (2014). Living with pulmonary hypertension: unique insights from an international ethnographic study. BMJ Open. 4(5). e004735–e004735. 38 indexed citations
13.
Kingman, Martha & Kelly Chin. (2013). Safety Recommendations for Administering Intravenous Prostacyclins in the Hospital. Critical Care Nurse. 33(5). 32–39. 8 indexed citations
14.
Poms, Abby & Martha Kingman. (2011). Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension. Critical Care Nurse. 31(6). e1–e10. 9 indexed citations
15.
Kingman, Martha, et al.. (2010). Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey. The Journal of Heart and Lung Transplantation. 29(8). 841–846. 38 indexed citations
17.
Kingman, Martha, Rosechelle Ruggiero, & Ferràn Torres. (2009). Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension. Expert Opinion on Pharmacotherapy. 10(11). 1847–1858. 36 indexed citations
18.
Chin, Kelly, Martha Kingman, James A. de Lemos, et al.. (2008). Changes in Right Ventricular Structure and Function Assessed Using Cardiac Magnetic Resonance Imaging in Bosentan-Treated Patients With Pulmonary Arterial Hypertension. The American Journal of Cardiology. 101(11). 1669–1672. 57 indexed citations
19.
Chin, Kelly, Martha Kingman, James A. deLemos, et al.. (2007). CHANGES IN RIGHT VENTRICULAR EJECTION FRACTION CORRELATE WITH CHANGES IN SIX-MINUTE WALK DISTANCE IN BOSENTAN-TREATED PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION. CHEST Journal. 132(4). 488A–488A. 1 indexed citations
20.
Kingman, Martha, et al.. (2005). Nesiritide for Pulmonary Arterial Hypertension With Decompensated Cor Pulmonale. Progress in Cardiovascular Nursing. 20(4). 168–172. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026